Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1862 (112th)

Regenerative Medicine Promotion Act of 2011

referredUnited States· United States Congress· EN

Introduced

12 May 2011

Last action

13 May 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Bilbray, Brian P. [R-CA-50], Rep. DeGette, Diana [D-CO-1], Rep. Dent, Charles W. [R-PA-15], Rep. Gerlach, Jim [R-PA-6], Rep. Holt, Rush [D-NJ-12], Rep. Fudge, Marcia L. [D-OH-11], Rep. Butterfield, G. K. [D-NC-1], Rep. Langevin, James R. [D-RI-2], Rep. Eshoo, Anna G. [D-CA-18], Rep. Capuano, Michael E. [D-MA-8], Rep. LaTourette, Steven C. [R-OH-14], Rep. Farr, Sam [D-CA-20], Rep. Frank, Barney [D-MA-4], Rep. McGovern, James P. [D-MA-2], Rep. Jackson, Jesse L., Jr. [D-IL-2], Rep. Burgess, Michael C. [R-TX-26], Rep. Rothman, Steven R. [D-NJ-9], Rep. Deutch, Theodore E. [D-FL-22], Sen. Murphy, Christopher [D-CT], Sen. Van Hollen, Chris [D-MD]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

Regenerative Medicine Promotion Act of 2011 - Requires the Comptroller General to submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine. Directs the Secretary of Health and Human Services (HHS) to establish a Regenerative Medicine Coordinating Council in the Office of the Secretary, the duties of which shall include: (1) preparing a national strategy to support research into regenerative medicine and the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; (2) identifying sources of funding for research into regenerative medicine and areas where such funding is inadequate; and (3) making recommendations regarding federal policies to support development and marketing of regenerative medicine products. Authorizes the Secretary, acting through the Director of the National Institutes of Health (NIH), to make grants for: (1) basic or preclinical research into regenerative medicine; (2) research and development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; and (3) the making of an investigational new drug application or an investigational device exemption application within four years of receiving such grant. Amends the Public Health Service Act to authorize the Director of NIH to award grants, contracts, or cooperative agreements to accelerate the development of high need cures through the development of medical products and behavioral therapies for use in regenerative medicine. Authorizes the Secretary, acting through the Commissioner of Food and Drugs, to: (1) conduct, support, or collaborate in regulatory research to assist the Food and Drug Administration (FDA) in performing its functions with respect to regenerative medicine; or (2) make grants to fund regulatory research for such purpose.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 12 May 2011

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 12 May 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 12 May 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 13 May 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 12 May 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 12 May 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 12 May 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.